Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nhung V Nguyen

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
PLOS Global Public Health|March 24, 2023
Evaluating novel engagement mechanisms, yields and acceptability of tuberculosis screening at retail pharmacies in Ho Chi Minh City, Viet NamPhuong M T Tran, Thu A Dam, Huy B Huynh, et al.
The Lancet. Public Health|March 25, 2021
Effectiveness and cost-effectiveness of a health systems intervention for latent tuberculosis infection management (ACT4): a cluster-randomised trialOlivia Oxlade, Andrea Benedetti, Mênonli Adjobimey, et al.
Emerging Infectious Diseases|March 2, 2025
Efficacy and Safety of 4-Month Rifapentine-Based Tuberculosis Treatments in Persons with DiabetesEkaterina V Kurbatova, William C Whitworth, Lakshmi Praveena Peddareddy, et al.
The New England Journal of Medicine|October 3, 2019
Community-wide Screening for Tuberculosis in a High-Prevalence SettingGuy B Marks, Nhung V Nguyen, Phuong T B Nguyen, et al.
Tropical Medicine and Infectious Disease|September 27, 2023
Comparing Catastrophic Costs: Active vs. Passive Tuberculosis Case Finding in Urban VietnamLuong V Dinh, Anja M C Wiemers, Rachel J Forse, et al.
The New England Journal of Medicine|May 5, 2021
Four-Month Rifapentine Regimens with or without Moxifloxacin for TuberculosisSusan E Dorman, Payam Nahid, Ekaterina V Kurbatova, et al.
Nature Communications|May 19, 2021
Mycobacterium tuberculosis precursor rRNA as a measure of treatment-shortening activity of drugs and regimensNicholas D Walter, Sarah E M Born, Gregory T Robertson, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
PLOS Global Public Health|March 24, 2023
Evaluating novel engagement mechanisms, yields and acceptability of tuberculosis screening at retail pharmacies in Ho Chi Minh City, Viet NamPhuong M T Tran, Thu A Dam, Huy B Huynh, et al.
The Lancet. Public Health|March 25, 2021
Effectiveness and cost-effectiveness of a health systems intervention for latent tuberculosis infection management (ACT4): a cluster-randomised trialOlivia Oxlade, Andrea Benedetti, Mênonli Adjobimey, et al.
Emerging Infectious Diseases|March 2, 2025
Efficacy and Safety of 4-Month Rifapentine-Based Tuberculosis Treatments in Persons with DiabetesEkaterina V Kurbatova, William C Whitworth, Lakshmi Praveena Peddareddy, et al.
The New England Journal of Medicine|October 3, 2019
Community-wide Screening for Tuberculosis in a High-Prevalence SettingGuy B Marks, Nhung V Nguyen, Phuong T B Nguyen, et al.
Tropical Medicine and Infectious Disease|September 27, 2023
Comparing Catastrophic Costs: Active vs. Passive Tuberculosis Case Finding in Urban VietnamLuong V Dinh, Anja M C Wiemers, Rachel J Forse, et al.
The New England Journal of Medicine|May 5, 2021
Four-Month Rifapentine Regimens with or without Moxifloxacin for TuberculosisSusan E Dorman, Payam Nahid, Ekaterina V Kurbatova, et al.
Nature Communications|May 19, 2021
Mycobacterium tuberculosis precursor rRNA as a measure of treatment-shortening activity of drugs and regimensNicholas D Walter, Sarah E M Born, Gregory T Robertson, et al.
Pageof 2